Serum, urine, and tissue samples were collected from 42 children undergoing open-heart surgery and analyzed for digoxin by radioimmunoassay. Of these, 24 had been digitalized prophylactically (RECENT) and 18 had been receiving maintenance therapy (MAINT) for one month or longer. Twenty-five percent of the RECENT patients exhibited arrhythmias during the postoperative period as compared to none in the MAINT group. Serum digoxin levels were equivalent in the two groups throughout the study. Although no change in tissue digoxin concentrations occurred during bypass, right atrial appendage concentrations were significantly higher in the RECENT group (109 vs 62 ng/g; P < 0.001). This high atrial digoxin concentration presumably resulted from the large doses used for initial digitalization, and concomitant with postoperative hypokalemia and myocardial metabolic changes secondary to perfusion, may have been responsible for the high incidence of arrhythmias in the RECENT group. Both digoxin and creatinine excretion were depressed following bypass. The amount of biotransformation of digoxin was 2-59.
tiating operatively-induced arrhythmias from those caused by digitalis toxicity.
Previous studies in dogs have demonstrated both an increased and decreased tolerance to cardiac glycosides following bypass.5 f Postoperative cardiac failure accompanied by conduction disturbances can lead to a situation wherein it is unclear whether to give more digoxin or to discontinue its administration. The decision to delay or not to administer digoxin is supported by observations of potassium7 and magnesium8 depletion following cardiopulmonary bypass which tend to sensitize the myocardium to digitalis toxicity.
Our goals were to 1) determine changes in serum concentrations of digoxin occurring during and after bypass. 2) relate these changes to urinary excretion, the major route of digoxin elimination, and 3) to study changes in digoxin levels in the right atrial appendage, skeletal muscle, and adipose tissue.
Methods

Patients and Dosage
Forty-two pediatric patients with congenital heart disease were hospitalized for corrective surgery. They were divided into two groups depending upon the duration of digoxin therapy (table 1). The mean values for age and weight differed significantly, since the patients in the maintenance group had developed cardiac failure at an earlier age, necessitating operative intervention. Although the recently digitalized patients were somewhat older and heavier, there 1047 was much overlap and the types of congenital defects were similar in both groups. Mean and range of bypass time were similar.
Twenty-four patients exhibited no evidence of heart failure but were prophylactically digitalized two to five days before surgery (RECENT). The Digoxin was measured by a radioimmunoassay (RIA) procedure developed in our laboratory,9 the antibody having an affinity of 3.6 X 10' M-l and Sips index of heterogeneity equal to 0.94. One-tenth ml aliquots of serum were assayed directly, while urine samples were diluted with distilled water to a concentration within the range of the assay (0.2 to 8 ng/ml). Tissue samples were homogenized in absolute ethanol for 30 sec with an Omnimixer (Ivan Sorvall, Inc., Norwalk, Conn.). The homogenates were centrifuged at 1000 g for 10 min and the supernatants removed. The precipitates were twice resuspended and centrifuged in additional ethanol. The combined supernatants were evaporated to dryness, and resuspended in phosphate-BSA buffer. After chronic administration of 3H-digoxin to guinea pigs, it was determined that 95% of digoxin was extracted from the myocardium, the extract reacting in the RIA with an affinity identical to that of nonextracted digoxin.'0 Serum electrolytes, blood urea nitrogen (BUN), and creatinine were determined by standard clinical laboratory techniques.
Separation of Metabolites
Urinary digoxin and metabolites were extracted in a manner similar to that previously described by Doherty et al." 12 An 0.5 ml aliquot of urine was saturated with sodium chloride, extracted three times with 4 ml of chloroform, and the volume of extract reduced to 1.0 ml. Recovery of digoxin and metabolites was greater than 90%. The extracts were then separated by thin-layer chromatography.3 Aliquots of each extract (approx. 100-200 ng) were applied to 20 X 20 cm silica gel-coated plates (Brinkmann Instruments, Des Plaines, Ill.) and allowed to dry. The middle lane of each plate contained a mixture of standards (digoxin, digoxigenin, and digoxigenin mono-and bisdigitoxosides). They were developed four times with isopropyl ether-methanol (9:1) and once with methyl ethyl ketone-chloroform (3:1), allowing time to air dry between developments. The lane containing the standards was isolated, sprayed with anisaldehyde reagent (0.5 ml anisaldehyde, 1.0 ml sulfuric acid, and 50 ml acetic acid), and placed in a 1000 oven for 5 min.'4 The lanes containing the extracts were divided into areas corresponding to the migration of the standards. Each area was scraped from the plate, and the gel eluted with 5 The serum digoxin level in each patient fell immediately after the onset of bypass and remained low but constant throughout the procedure. Shortly after bypass was discontinued, the serum level rose and reached the prebypass level within two hours.
Mean serum digoxin levels were equal in the groups prior to bypass (1.2 ± 0.1 ng/ml*). During bypass the levels in both groups fell significantly (P < 0.01) to 0.7 ± 0.1. By seven hours postbypass the levels in both groups returned to the prebypass value, but again fell significantly after ten hours (P < 0.02). At no time did the mean serum levels in the two groups differ.
Tissue Digoxin
No change digoxin levels in the atrial appendage occurred during surgery in either group ( fig. 2) . The pre-and postbypass-atrial concentrations in the RECENT group, 109 ± 9 (88-174) and 104 ± 5 (94-124) ng/g, were 60% higher than in the MAINT group, 62 ± 6 (30-113, P < 0.001) and 67 ± 15 (44-111, P < 0.05) ng/g, respectively.
Skeletal muscle and subcutaneous adipose tissue digoxin levels, which were considerably lower than atrial digoxin, also remained unchanged after bypass ( fig. 2) . Unlike atrial tissue, however, the digoxin levels in the MAINT skeletal muscle, 24 + 7 (6-32) and 14 ± 3 (10-21) ng/g, were significantly higher than those found in the RECENT group, 8 + 1 (5-10, P < 0.01) and 8 ± 1 (5-11, P < 0.02) ng/g, respectively. Subcutaneous tissue digoxin concentrations were equal.
Urine Digoxin
Urine was collected from 14 RECENT and nine MAINT patients. Although there was no difference between the two groups, the rate of digoxin excretion was significantly lower (P < 0.01) durint. and 15 hours after bypass. Creatinine excretion was sifilarly lower during these periods.
Since serum digoxin and creatinine levels changed during the study period, clearance values were calculated whenever possible. Following bypass the clearance values in both groups were significantly lower than before surgery ( fig. 3) creatinine clearances fell to 50% of their prebypass levels.
Nineteen prebypass urine samples (10 RECENT and 9 MAINT) were extracted, chromatographed, and assayed ( were in normal sinus rhythm postoperatively. These findings did not correlate with serum digoxin, electrolyte levels, or creatinine clearance, for levels were the same in both groups throughout the study. Whereas bypass itself had no effect on digoxin concentrations in the atrium, skeletal muscle, or subcutaneous adipose tissue, the mean atrial digoxin concentration in the RECENT group was significantly higher than that in the MAINT group. This relatively high concentration probably resulted from the large doses used for digitalization. It seems likely that hypokalemia and myocardial metabolic changes secondary to perfusion may have been sufficient to lower digoxin tolerance to a degree that the relatively high myocardial digoxin levels in the RECENT group precipitated arrhythmias. Table 2 Urinary Digoxin, Digoxigenin-Bis-Digitoxoskde (Bis), Digoxigenin-Mono-Digitoxoside (Mono), and Digoxigenin (Genin), as Compared to a Typical Lanoxin Preparation (Lanoxin).
Origin Digoxin The rapid decrease in serum levels we observed has been reported by others'6' 1,1 and seemed due to dilution by perfusate. Although determination of the volume changes in the vascular compartment is difficult because of redistribution, if one assumes an initial plasma volume of 51 ml/kg,20 the total priming volume of 20 ml/kg would dilute the plasma by 30%. Additional dilution occurs due to the intraoperative administration of large volumes of fluid. Our data show that serum digoxin fell 40% and the hematocrit 45%, values which are compatible with the fall predicted from hemodilution alone.
Studies The constancy of myocardial digoxin during bypass has also been demonstrated previously in both dogs"' and man.17' 23 One group, however, has reported a 15-24% decrease in myocardial digoxin concomitant with a fivefold increase in serum digoxin in both species. '4 15 No apparent explanation could be found for these discrepancies.
The decrease in glomerular filtration during the postoperative period as shown by lowered digoxin and creatinine clearances has been reported in adults by Coltart et al.,"6 and suggested in dogs by a lengthened serum half-life.25 Considering that 75-90% of an i.v. dose of digoxinis excreted in the urine,26' 27 extreme caution is necessary in readministering digoxin during the early postoperative period.
The amount of chloroform-extractable urinary metabolites of digoxin was extremely low (2 to 5%) and agrees with values for infants and children12' 28 and studies in adults which have found less than 10% metabolites in urine.26 29 Only one study has reported the presence of water-soluble metabolites following oral digoxin.T he following procedures are recommended for children undergoing open-heart surgery: 1) when prophylactic digitalization is planned, it probably should be initiated four weeks or longer before surgery, 2) serum digoxin levels should be determined preoperatively to assure that they are within normal limits (1-2 ng/ml), 3) additional digoxin should generally not be given for at least ten hours following bypass, 4) postoperative dosage should be modified in relation to the patient's creatinine clearance31 and his or her serum digoxin level as periodically monitored, and 5) serum levels of K+ and Mg++ should be monitored and their losses replaced within 12 hours after surgery.
